The COOH terminus of Rho-kinase negatively regulates Rho-kinase activity

The COOH terminus of Rho-kinase negatively regulates Rho-kinase activity
复制标题

DOI:
10.1074/jbc.274.45.32418
复制
发表时间:
1999-11-05
影响因子:
4.8
通讯作者:
Kaibuchi, K
Kaibuchi, K
中科院分区:
生物学2区
文献类型:
--
作者:
Amano, M;Chihara, K;Kaibuchi, K

文献摘要

被引文献

相似文献

Rho激酶参与Rho下游肌球蛋白轻链的磷酸化,其被认为诱导非肌肉细胞中的平滑肌收缩和应力纤维形成。在这里,我们研究了Rho激酶抑制剂的作用方式。化合物如HA 1077和Y-32885不仅抑制Rho-激酶活性,而且抑制Rho的靶标之一蛋白激酶N的活性,但对强直性肌营养不良激酶相关Cdc 42-结合激酶β(MRCK β)的活性影响较小。含有Rho结合(RB)和普列克底物蛋白同源(PH)结构域的Rho激酶的COOH末端部分(RB/PH(TT)),其中引入点突变以消除Rho结合活性,与Rho-激酶相互作用,从而抑制Rho-激酶活性,而RB/PH(TT)对蛋白激酶N或MRCK β的活性没有影响,表明Rho激酶的COOH末端区域可能是Rho激酶的负调控区域。RB/PH(TT)的表达可特异性阻断Rho或Rho激酶活性形式诱导的NIH 3 T3细胞应力纤维和粘着斑的形成,但不能阻断MRCK β或肌球蛋白轻链活性形式诱导的应力纤维和粘着斑的形成。因此,RB/PH(TT)似乎在体内特异性抑制Rho激酶。
Rho-kinase is implicated in the phosphorylation of myosin Light chain downstream of Rho, which is thought to induce smooth muscle contraction and stress fiber formation in non-muscle cells. Here, we examined the mode of action of inhibitors of Rho-kinase. The chemical compounds such as HA1077 and Y-32885 inhibited not only the Rho-kinase activity but also the activity of protein kinase N, one of the targets of Rho, but had less of an effect on the activity of myotonic dystrophy kinase-related Cdc42-binding kinase beta (MRCK beta). The COOH-terminal portion of Rho-kinase containing Rho-binding (RB) and pleckstrin homology (PH) domains (RB/PH (TT)), in which point mutations were introduced to abolish the Rho binding activity, interacted with Rho-kinase and thereby inhibited the Rho-kinase activity, whereas RB/PH (TT) had no effect on the activity of protein kinase N or MRCK beta, suggesting that the COOH-terminal region of Rho-kinase is a possible negative regulatory region of Rho-kinase. The expression of RB/PH (TT) specifically blocked the stress fiber and focal adhesion formation induced by the active form of Rho or Rho-kinase in NIH 3T3 cells, but not that induced by the active form of MRCK beta or myosin light chain. Thus, RB/PH (TT) appears to specifically inhibit Rho kinase in vivo.